Compounded Semaglutide: Weight Management Medicine Facts
Comments Off on Compounded Semaglutide: Weight Management Medicine Facts
April 13, 2026
Compounded GLP-1 therapy offers an alternative approach to weight management with semaglutide. This therapy lacks FDA approval as a finished drug product, raising safety considerations. Telehealth prescribing of compounded semaglutide requires careful…
Clinical Evidence on GLP-1 Receptor Agonist Telehealth Transition
Comments Off on Clinical Evidence on GLP-1 Receptor Agonist Telehealth Transition
April 13, 2026
GLP-1 receptor agonist telehealth transition is reshaping patient access to therapies. The phase-out of compounded semaglutide highlights regulatory shifts toward FDA-approved medications. Clinicians must adapt to these changes to ensure continuity of…